Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Pomeranian Journal of Life Sciences
Volume 69 (2023): Issue 4 (December 2023)
Open Access
Benefits of administering GLP-1 analogs to patients with polycystic ovary syndrome, considering their effect on adipose tissue metabolism
Małgorzata Król
Małgorzata Król
,
Justyna Żychowska
Justyna Żychowska
,
Ryszard Łagowski
Ryszard Łagowski
,
Patrycja Kupnicka
Patrycja Kupnicka
,
Donata Simińska
Donata Simińska
and
Dariusz Chlubek
Dariusz Chlubek
| Dec 26, 2023
Pomeranian Journal of Life Sciences
Volume 69 (2023): Issue 4 (December 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 26, 2023
Page range:
32 - 37
DOI:
https://doi.org/10.21164/pomjlifesci.965
Keywords
glucagon-like peptide-1 agonists
,
adipose tissue
,
obesity
,
polycystic ovary syndrome
© 2023 Małgorzata Król et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.